Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis

References

• Harding JJ, Abu-Zeinah G, Chou JF, et al. Frequency, morbidity, and mortality of bone metastases in advanced hepatocellular Carcinoma. J Natl Compr Canc Netw. 2018;16(1):50–58. doi:10.6004/jnccn.2017.702429295881
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.29628281
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370.28620797
   PubMed Web of Science ®Google Scholar
• Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20(11):1781–1787. doi:10.1111/j.1440-1746.2005.03919.x16246200
   PubMed Web of Science ®Google Scholar
• Zhang S-M, Zeng Z-C, Tang Z-Y, et al. Prognostic analysis of pulmonary metastases from hepatocellular carcinoma. Hepatol Int. 2008;2(2):237–243. doi:10.1007/s12072-008-9052-719669310
   PubMed Web of Science ®Google Scholar
• Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007;25(11):1316–1322. doi:10.1200/JCO.2006.06.121817416852
   PubMed Web of Science ®Google Scholar
• Valentini V, van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–3172. doi:10.1200/JCO.2010.33.159521747092
   PubMed Web of Science ®Google Scholar
• Song W, Zhu ZG, Wu Q, et al. A nomogram to predict overall survival for biliary tract cancer. Cancer Manag Res. 2018;10:1535–1541. doi:10.2147/CMAR.S16329129942155
   PubMed Web of Science ®Google Scholar
• Hu Z, Huang P, Zhou Z, et al. Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis. Clin Transl Oncol. 2018;20(6):729–739. doi:10.1007/s12094-017-1779-y29110217
   PubMed Web of Science ®Google Scholar
• Ishii T, Hatano E, Yasuchika K, Taura K, Seo S, Uemoto S. High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter. Surg Today. 2014;44(10):1900–1905.24264061
   PubMed Web of Science ®Google Scholar
• Tanaka T, Hiramatsu K, Nosaka T, et al. Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report. BMC Cancer. 2015;15(1):863. doi:10.1186/s12885-015-1831-726545979
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Ikeda N, Nakajima J, et al. Prognostic analysis of surgical resection for pulmonary metastasis from hepatocellular carcinoma. World J Surg. 2016;40(9):2178–2185. doi:10.1007/s00268-016-3580-427255943
   PubMed Web of Science ®Google Scholar
• Pomerri F, Pucciarelli S, Maretto I, et al. Significance of pulmonary nodules in patients with colorectal cancer. Eur Radiol. 2012;22(8):1680–1686. doi:10.1007/s00330-012-2431-422466515
   PubMed Web of Science ®Google Scholar
• Lee JI, Kim JK, Kim DY, et al. Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions. Clin Exp Metastasis. 2014;31(4):475–482. doi:10.1007/s10585-014-9641-x24496959
   PubMed Web of Science ®Google Scholar
• Yang A, Xiao W, Chen D, et al. The power of tumor sizes in predicting the survival of solitary hepatocellular carcinoma patients. Cancer Med. 2018;7(12):6040–6050. doi:10.1002/cam4.187330430769
   PubMed Web of Science ®Google Scholar
• Hwang S, Lee YJ, Kim KH, et al. The impact of tumor size on long-term survival outcomes after resection of solitary hepatocellular carcinoma: single-institution experience with 2558 patients. J Gastrointest Surg. 2015;19(7):1281–1290. doi:10.1007/s11605-015-2849-525956724
   PubMed Web of Science ®Google Scholar
• Goh BK, Teo JY, Chan CY, et al. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system. J Surg Oncol. 2016;113(1):89–93. doi:10.1002/jso.2409926611492
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Kelley RK, Venook AP. A review of hepatocellular carcinoma (HCC) staging systems. Chin Clin Oncol. 2013;2(4):33. doi:10.3978/j.issn.2304-3865.2013.07.0525841912
   PubMedGoogle Scholar
• Dai CY, Lin CY, Tsai PC, et al. Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection. J Chin Med Assoc. 2018;81(2):155–163. doi:10.1016/j.jcma.2017.06.01829217359
   PubMed Web of Science ®Google Scholar
• Zhang W, Jin K, Wang F, et al. Differences in the prognostic value of tumor size on hepatocellular cancer-specific survival stratified by gender in a SEER population-based study. United European Gastroenterol J. 2019;7(7):933–941. doi:10.1177/2050640619845602
   PubMed Web of Science ®Google Scholar
• Sauzay C, Petit A, Bourgeois AM, et al. Alpha-foetoprotein (AFP): a multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta. 2016;463:39–44. doi:10.1016/j.cca.2016.10.00627732875
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun HC, Wang Z, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition). Liver Cancer. 2018;7(3):235–260. doi:10.1159/00048803530319983
   PubMed Web of Science ®Google Scholar
• Liu PH, Huo TI, Miksad RA. Hepatocellular carcinoma with portal vein tumor involvement: best management strategies. Semin Liver Dis. 2018;38(3):242–251. doi:10.1055/s-0038-166680530041276
   PubMed Web of Science ®Google Scholar
• Lee SU, Park JW, Kim TH, et al. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol. 2014;190(9):806–814. doi:10.1007/s00066-014-0604-624589917
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Yoshida K, Nishimura H, et al. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res. 2016;57(5):512–523. doi:10.1093/jrr/rrw02827053259
   PubMed Web of Science ®Google Scholar
• Xi M, Zhang L, Zhao L, et al. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. PLoS One. 2013;8(5):e63864. doi:10.1371/journal.pone.006386423737955
   PubMed Web of Science ®Google Scholar
• Yeh SA, Chen YS, Perng DS. The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. J Radiat Res. 2015;56(2):325–331. doi:10.1093/jrr/rru10425411553
   PubMed Web of Science ®Google Scholar
• Bae BK, Kim JC. The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy. Radiat Oncol J. 2016;34(3):168–176. doi:10.3857/roj.2016.0166927545294
   PubMedGoogle Scholar
• Nakanishi M, Umeda Y, Demura Y, et al. Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases. Lung Cancer. 2007;55(2):241–247. doi:10.1016/j.lungcan.2006.10.00817098326
   PubMed Web of Science ®Google Scholar
• Tomimaru Y, Sasaki Y, Yamada T, et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg. 2006;192(1):46–51. doi:10.1016/j.amjsurg.2005.12.00616769274
   PubMed Web of Science ®Google Scholar
• Lee CY, Bae MK, Park IK, et al. Surgical resection for pulmonary metastasis from hepatocellular carcinoma: analysis of prognosis in relation to primary control. J Surg Oncol. 2010;101(3):239–243.
   Google Scholar